US20060135806A1 - Process for the purification of 1,4-butanediol mononitrate - Google Patents
Process for the purification of 1,4-butanediol mononitrate Download PDFInfo
- Publication number
- US20060135806A1 US20060135806A1 US10/534,867 US53486705A US2006135806A1 US 20060135806 A1 US20060135806 A1 US 20060135806A1 US 53486705 A US53486705 A US 53486705A US 2006135806 A1 US2006135806 A1 US 2006135806A1
- Authority
- US
- United States
- Prior art keywords
- extraction
- bdmn
- water
- butanediol
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 28
- FBOGSWRRYABFKU-UHFFFAOYSA-N 4-hydroxybutyl nitrate Chemical compound OCCCCO[N+]([O-])=O FBOGSWRRYABFKU-UHFFFAOYSA-N 0.000 title claims abstract description 13
- 238000000746 purification Methods 0.000 title abstract description 8
- 238000000605 extraction Methods 0.000 claims abstract description 50
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 claims abstract description 18
- QELUAJBXJAWSRC-UHFFFAOYSA-N 4-nitrooxybutyl nitrate Chemical compound [O-][N+](=O)OCCCCO[N+]([O-])=O QELUAJBXJAWSRC-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000002904 solvent Substances 0.000 claims abstract description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 68
- 239000000243 solution Substances 0.000 claims description 33
- 239000003960 organic solvent Substances 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 239000007864 aqueous solution Substances 0.000 claims description 10
- 239000008346 aqueous phase Substances 0.000 claims description 7
- QPFMBZIOSGYJDE-UHFFFAOYSA-N 1,1,2,2-tetrachloroethane Chemical compound ClC(Cl)C(Cl)Cl QPFMBZIOSGYJDE-UHFFFAOYSA-N 0.000 claims description 6
- 238000000926 separation method Methods 0.000 claims description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 3
- 229950005499 carbon tetrachloride Drugs 0.000 claims description 3
- 229960001701 chloroform Drugs 0.000 claims description 3
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 claims description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 27
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 17
- 229910017604 nitric acid Inorganic materials 0.000 description 15
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 239000004202 carbamide Substances 0.000 description 6
- 238000006396 nitration reaction Methods 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000004821 distillation Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 239000002360 explosive Substances 0.000 description 4
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 3
- 239000012045 crude solution Substances 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000010908 decantation Methods 0.000 description 2
- AKFJWRDCWYYTIG-ZDUSSCGKSA-N naproxcinod Chemical compound C1=C([C@H](C)C(=O)OCCCCO[N+]([O-])=O)C=CC2=CC(OC)=CC=C21 AKFJWRDCWYYTIG-ZDUSSCGKSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- 206010059024 Gastrointestinal toxicity Diseases 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 239000000006 Nitroglycerin Substances 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- -1 chloromethylene Chemical group 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 231100000414 gastrointestinal toxicity Toxicity 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C203/00—Esters of nitric or nitrous acid
- C07C203/02—Esters of nitric acid
- C07C203/04—Esters of nitric acid having nitrate groups bound to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
- C07C201/02—Preparation of esters of nitric acid
Definitions
- the present invention relates to a process for the purification of 1,4-butanediol mononitrate (BDMN) from 1,4-butanediol dinitrate (BDDN) and 1,4-butanediol (BD) in an efficient, easily controllable way, which is therefore safer for operators.
- BDMN 1,4-butanediol mononitrate
- BDDN 1,4-butanediol dinitrate
- BD 1,4-butanediol
- NO-NSAIDs nitric oxide (NO)-releasing NSAIDs
- NO-NSAIDs i.e. non-steroidal anti-inflammatory drugs which release nitric oxide.
- NO-NSAIDs have antipyretic and anti-inflammatory activities, but lower gastrointestinal toxicity than other non-steroidal anti-inflammatory medicaments.
- examples of NO-NSAIDs are NO-acetylsalicylic acid, NO-diclofenac, NO-naproxen, NO-ketoprofen and NO-ibuprofen.
- NO-naproxen is described, for example, in WO 01/10814.
- BDMN obtained by mono-nitration of BD has to be separated from unreacted BDDN and BD.
- BDMN has, like BDDN, explosive characteristics, therefore neither crystallization nor distillation techniques can be employed.
- both BDMN and BDDN are liquid at room temperature and they can decompose upon crystallization due to friction or impaction.
- distillation involves evident hazards owing to the recovery of the explosive compound in the pure form.
- distillation of a mixture containing BDDN and BDMN would require heating to a temperature at which spontaneous, explosive decomposition could take place.
- BDMN can be selectively separated from BD and BDDN in industrially advantageous yields by subsequent extractions with water and a water-immiscible organic solvent.
- Object of the present invention is therefore a process for the separation of 1,4-butanediol mononitrate from a solution of 1,4-butanediol dinitrate and 1,4-butanediol in a water-immiscible organic solvent, which process comprises the following steps:
- the invention comprises a further step c), which consists in washing the aqueous solution exiting from the extraction column “(A)” with the same organic solvent used in the subsequent step b). Said washing allows to remove BDDN from the aqueous phase before subjecting it to step b).
- the invention comprises a further step d) in which the residual organic solution from step a) is extracted with the aqueous phase exiting from column (B).
- the resulting BDMN-enriched aqueous solution is recycled to the first extraction column (A).
- Typical water-immiscible organic solvents which can be used according to the invention are chlorinated solvents, for example C1-C4 alkyl mono-, di-, tri- or tetrachlorides, preferably dichloromethane, trichloromethane, tetrachloromethane, trichloroethane and tetrachloroethane, in particular dichloromethane.
- chlorinated solvents for example C1-C4 alkyl mono-, di-, tri- or tetrachlorides, preferably dichloromethane, trichloromethane, tetrachloromethane, trichloroethane and tetrachloroethane, in particular dichloromethane.
- the water-immiscible organic solvent in the solution of BD, BDMN and BDDN to be subjected to the separation process and the water-immiscible organic solvent used in the extraction according to step b) are the
- the process according to the invention consists of one or more extraction cycles with water and a water-immiscible organic solvent according to steps a) and b) and optionally of steps c) and/or d).
- the process comprises 1 to 4 a) and b) cycles, preferably 2 or 3, most preferably 2.
- the organic solution containing purified BDMN obtained with the process of the invention can be concentrated.
- a further object of the invention is highly pure 1,4-butanediol mononitrate, typically higher than 99% pure, as obtainable by the process of the invention.
- a further object of the invention is a solution of 1,4-butanediol mononitrate in a water-immiscible organic solvent, substantially free from 1,4-butanediol dinitrate, as obtainable by the process of the invention.
- the solution containing BDMN, BDDN and BD to be subjected to the extraction process according to the invention can be obtained either with conventional synthetic methods in a water-immiscible solvent or with a novel process for the mononitration of 1,4-butanediol, which is a further object of the invention.
- Said method consists in the nitration of 1,4-butanediol by treatment with “stabilized” nitric acid in a water-immiscible organic solvent selected from those defined above.
- stabilized nitric acid means a nitric acid solution diluted with water, having concentration ranging from about 83 to about 85%, preferably from about 84.5 to about 84.8%, and substantially free from nitrous acid and nitrogen oxides.
- substantially free from nitrous acid and nitrogen oxides means that their concentration is typically lower than 10 ppm, preferably lower than 5 ppm. Said “stabilized” nitric acid is also an object of the present invention.
- the preparation of “stabilized” nitric acid can be carried out, for example, by dilution of fuming nitric acid with water to a concentration ranging from about 83 to about 85% followed by treatment with an amount of an agent able to remove nitrous acid and nitrogen oxides present therein.
- Said agent can be, for example, urea or sulfamic acid, preferably urea, in amounts ranging from about 0.3 to about 1% w/w.
- the same result can be obtained by addition of an aqueous solution of said agent to fuming nitric acid.
- the contact time of said agent with nitric acid required to completely remove the nitrous acid and nitrogen oxides ranges from about 80 minutes to about 130 minutes.
- the agent is urea
- the amount ranges from about 0.6 to about 1% w/w, preferably from about 0.7 to about 1% w/w and the contact time preferably ranges from about 95 to about 120 minutes.
- the “stabilized” nitric acid according to the invention should be used within approx. three hours from stabilization, as in time nitrous acid and nitrogen oxides are released again in such concentrations as to trigger strong decomposition reactions.
- the weight ratio of “stabilized” nitric acid to 1,4-butanediol preferably ranges from about 11:1 to about 14.5:1 and the nitration is preferably carried out for a time ranging between about 10 and about 30 minutes.
- the nitrated solution can be treated to remove by-products and unreacted starting products, then suitably concentrated.
- Said solution is, in fact, a crude mixture of BDMN, by-product BDDN, unreacted BD and nitric acid in the organic solvent, also containing other by-products deriving from dehydration and/or oxidation.
- the solution is first partially neutralized with a sodium hydroxide concentrated solution, thus extracting most of the unreacted BD in the resulting sodium nitrate aqueous solution.
- the organic phase is then concentrated by evaporation and neutralized with a diluted basic solution.
- the solution subjected to the separation process of the invention preferably contains BDMN in amounts ranging from about 11% to about 15% w/w, preferably 11% w/w; BDDN in amounts ranging from about 3 to about 4.5% w/w, preferably 4%; BD in amounts ranging from about 0.2 to about 0.8% w/w (with respect to BDMN).
- BDMN in amounts ranging from about 11% to about 15% w/w, preferably 11% w/w
- BDDN in amounts ranging from about 3 to about 4.5% w/w, preferably 4%
- BD in amounts ranging from about 0.2 to about 0.8% w/w (with respect to BDMN).
- the extraction according to steps a) and b) is preferably carried out using two or more liquid-liquid counter-current extraction columns, preferably two, three or four, more preferably two, herein referred to as column (A), for step a) and column (B), for step b).
- Columns (A) and (B) are preferably plate columns having 45-55 plates and optionally a decanter at the top and one at the bottom.
- Particularly suitable are liquid-liquid counter-current extraction columns for nominal flow rates of about 5-50 l/h, with a decanter at the top and one at the bottom.
- said extractions are carried out with columns mod. E60/50G from kuhni (Basilea-Switzerland).
- the two extractions are carried out at temperatures compatible with the thermal stability of BDMN and BDDN, namely at a temperature below the boiling point of the organic solvent, preferably at room temperature.
- FIG. 1 shows the essential elements of a purification plant according to the invention, namely extraction column (A), extraction column (B) and a reactor (C) for the optional step c), wherein the process is carried out using dichloromethane as the solvent.
- dichloromethane is replaced with an organic solvent lighter than water, fluids will be fed to the extraction columns (A) and (B) in an opposite manner.
- the dichloromethane solution of BDMN, BDDN and BD i.e. the “crude” obtainable form the treatment described above, is fed to the top of a first extraction column (A), while water is fed to the bottom of said column. All the residual BD, most of the BDMN and a very small aliquot of BDDN in aqueous solution exit the top decanter of column (A).
- the raffinate consisting of a dichloromethane solution containing most of the BDDN and a small amount of BDMN exits the bottom of the column.
- the aqueous solution of BDMN, residual BD and the very small amount of BDDN from the first extraction column (A) is fed to the base of a second extraction column (B), while fresh dichloromethane is fed to the head.
- Water with all the residual BD and some BDMN exit the head of the second column, while the extract, i.e. a dichoromethane solution containing purified BDMN and the negligible amount of BDDN, exit the bottom.
- Optional step c which is carried out in an extractor (C), allows to increase the purity level of BDMN and can be effected as follows.
- the aqueous solution exiting the first extraction column (A) is treated with a suitable amount of dichloromethane ranging from about 7 to about 20% w/w with respect to the chloromethylene solution fed to the column (A).
- Treatment allows to remove BDDN which, although sparingly water-soluble (solubility ⁇ 0.05%), is still present at rather high concentrations compared with BDMN (approx. 1-2%).
- Extractor (C) can be, for example, a conventional reactor, with a decanter downstream. After decantation, the aqueous phase now substantially containing only BDMN and the residual BD is fed to the second extraction column (B). The organic phase containing BDDN is recycled.
- step d the aqueous phase from the second extraction column (B), containing a very small amount of BDMN, is mixed with the dichloromethane raffinate from column (A), which in turn contains a small amount of BDMN. Extraction and subsequent decantation provide an aqueous phase enriched in BDMN, which is recycled to the first extraction column (A). In this manner, yield in BDMN can be further increased.
- the process of the invention allows to separate BDMN from BD and BDDN with low hazards, good selectivity and high yields.
- the extraction yield (expressed as percentage ratio of purified BDMN to BDMN present in the crude solution) is above 90% w/w.
- the resulting organic solution contains highly pure BDMN, typically above 99.0% pure.
- the dichloromethane solution contains BDMN with purity from about 99.5 to about 99.9%, in amounts ranging from about 5 to about 8% w/w.
- the solution is therefore substantially free from BDDN.
- the residual amount of BDDN in the organic solvent is, in fact, below 0.2% and in case of dichloromethane is below 0.15%.
- the purified BDMN organic solution can be finally concentrated, for example under reduced pressure, to a concentration of about 15% w/w in order to make transport or storage easier.
- concentration of about 15% w/w in order to make transport or storage easier.
- the use of solutions with higher BDMN contents can be potentially dangerous to operators.
- the crude solution (containing about 11% BDMN and about 4% BDDN) is fed (6.5 kg/h) to the top of the first column, wherein it encounters the extracted water (42.3 kg/h) (containing about 0.3% of BDMN) that exit the top of the second column and flows backwards.
- the raffinate (containing about 0.6% BDMN and about 6% BDDN) exits the bottom of the first column and extraction water (42.9 kg/h), rich in BDMN (about 1.6% BDMN and ⁇ 0.05% BDDN) exits the top and is passed through de-emulsifier, then fed to the bottom of the second column, wherein it encounters fresh dichloromethane flowing backwards (11.1/h).
- Water with some BDMN exits the top of second column and is recycled to the first column, while the dichloromethane solution containing purified BDMN (about 6% w/w BDMN) exits the bottom.
- BDMN which has 99.5% purity (0.5% of BDDN) in the extract, is then concentrated to 15% w/w.
- the extraction yield expressed as the ratio of purified BDMN to BDMN present in the crude solution, is about 94% w/w.
- the plant is substantially the same as that of example 1, in which a 5 liters reactor equipped with a stirring system and a separator is fitted between the two distillation columns.
- BDDN solubilised in the water exiting the top of the first column is extracted with dichloromethane (1.0 kg/h) and recycled after separation.
- the final extract is thus sufficiently pure (BDDN ⁇ 0.1%).
- a stainless steel reactor equipped with condenser and stirrer, is loaded with 90 kg of diluted nitric acid (84.7%), with nitrous acid content of approx. 0.09%.
- the nitric acid solution is added with 675 g of urea beads, under stirring.
- the solution is kept under stirring for about 90 minutes, then disappearance of all the nitrous acid and nitrogen oxides is checked, both by observation of the color of the solution and determination with permanganate. If necessary, further urea is added in small portions, until complete removal of the nitrous acid and nitrogen oxides.
- a stainless steel reactor is loaded in succession with 931 g of dichloromethane and 385 g of “stabilized” nitric acid.
- the dispersion is cooled to about 0° C. under stirring, then 50 g of a 70/30 solution of 1,4-butanediol in dichloromethane is added in a single portion.
- the reaction mixture is kept under stirring at temperatures ranging from about ⁇ 2° C. to 2° C. Nitration kinetics is monitored on samples of the reaction mixture. After 20 minutes the reaction is quickly quenched by pouring it into an ice/water (385 g) mixture, then neutralized with 433 g of 40% NaOH, keeping the temperature below 15° C.
- the organic phase containing 1,4-butanediol-mononitrate (19.2 g), 1,4-butanediol-dinitrate (6.4 g) and 1,4-butanediol (0.1 g) is then separated and subjected to the subsequent purification.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Polyesters Or Polycarbonates (AREA)
Abstract
Description
- The present invention relates to a process for the purification of 1,4-butanediol mononitrate (BDMN) from 1,4-butanediol dinitrate (BDDN) and 1,4-butanediol (BD) in an efficient, easily controllable way, which is therefore safer for operators.
- BDMN is a key intermediate in the synthesis of nitric oxide (NO)-releasing NSAIDs, i.e. non-steroidal anti-inflammatory drugs which release nitric oxide. NO-NSAIDs have antipyretic and anti-inflammatory activities, but lower gastrointestinal toxicity than other non-steroidal anti-inflammatory medicaments. Examples of NO-NSAIDs are NO-acetylsalicylic acid, NO-diclofenac, NO-naproxen, NO-ketoprofen and NO-ibuprofen. The preparation of NO-naproxen is described, for example, in WO 01/10814.
- The industrial production of BDMN by reduction or hydrolysis from BDDN, is problematic and poorly selective, as the synthesis of BDDN involves problems concerning production, storage and transport similar to those connected with the use of nitroglycerin.
- Mono-nitration of BD with the methods available to date is also problematic and poorly selective on an industrial scale, as dangerous decomposition reactions easily occur when a strong oxidizer (nitric acid) is contacted with an unstable substrate.
- Moreover, BDMN obtained by mono-nitration of BD has to be separated from unreacted BDDN and BD. Such separation is, however, potentially dangerous, in that BDMN has, like BDDN, explosive characteristics, therefore neither crystallization nor distillation techniques can be employed. In fact, both BDMN and BDDN are liquid at room temperature and they can decompose upon crystallization due to friction or impaction. Analogously, distillation involves evident hazards owing to the recovery of the explosive compound in the pure form. In view of their chemical-physical characteristics, distillation of a mixture containing BDDN and BDMN would require heating to a temperature at which spontaneous, explosive decomposition could take place.
- There is therefore need for a process for the purification of BDMN from BD and BDDN which avoids crystallization or distillation.
- It has now been found that BDMN can be selectively separated from BD and BDDN in industrially advantageous yields by subsequent extractions with water and a water-immiscible organic solvent.
- Object of the present invention is therefore a process for the separation of 1,4-butanediol mononitrate from a solution of 1,4-butanediol dinitrate and 1,4-butanediol in a water-immiscible organic solvent, which process comprises the following steps:
-
- a) extraction of BDMN from said solution by water;
- b) extraction of BDMN from the resulting aqueous solution, by an organic solvent immiscible with water.
- According to a preferred aspect, the invention comprises a further step c), which consists in washing the aqueous solution exiting from the extraction column “(A)” with the same organic solvent used in the subsequent step b). Said washing allows to remove BDDN from the aqueous phase before subjecting it to step b).
- According to a further preferred aspect, the invention comprises a further step d) in which the residual organic solution from step a) is extracted with the aqueous phase exiting from column (B). The resulting BDMN-enriched aqueous solution is recycled to the first extraction column (A).
- Typical water-immiscible organic solvents which can be used according to the invention are chlorinated solvents, for example C1-C4 alkyl mono-, di-, tri- or tetrachlorides, preferably dichloromethane, trichloromethane, tetrachloromethane, trichloroethane and tetrachloroethane, in particular dichloromethane. Preferably, the water-immiscible organic solvent in the solution of BD, BDMN and BDDN to be subjected to the separation process and the water-immiscible organic solvent used in the extraction according to step b) are the same.
- The process according to the invention consists of one or more extraction cycles with water and a water-immiscible organic solvent according to steps a) and b) and optionally of steps c) and/or d). Preferably, the process comprises 1 to 4 a) and b) cycles, preferably 2 or 3, most preferably 2.
- If desired, the organic solution containing purified BDMN obtained with the process of the invention can be concentrated.
- A further object of the invention is highly pure 1,4-butanediol mononitrate, typically higher than 99% pure, as obtainable by the process of the invention.
- A further object of the invention is a solution of 1,4-butanediol mononitrate in a water-immiscible organic solvent, substantially free from 1,4-butanediol dinitrate, as obtainable by the process of the invention.
- Solutions of 1,4-butanediol mononitrate substantially free from 1,4-butanediol dinitrate in an organic solvent selected from dichloromethane, trichloromethane, tetrachloromethane, tricloethane and tetrachloroethane, in particular dichloromethane, are preferred.
- The solution containing BDMN, BDDN and BD to be subjected to the extraction process according to the invention can be obtained either with conventional synthetic methods in a water-immiscible solvent or with a novel process for the mononitration of 1,4-butanediol, which is a further object of the invention.
- Said method consists in the nitration of 1,4-butanediol by treatment with “stabilized” nitric acid in a water-immiscible organic solvent selected from those defined above.
- The expression “stabilized” nitric acid means a nitric acid solution diluted with water, having concentration ranging from about 83 to about 85%, preferably from about 84.5 to about 84.8%, and substantially free from nitrous acid and nitrogen oxides. The expression “substantially free from nitrous acid and nitrogen oxides” means that their concentration is typically lower than 10 ppm, preferably lower than 5 ppm. Said “stabilized” nitric acid is also an object of the present invention.
- The preparation of “stabilized” nitric acid can be carried out, for example, by dilution of fuming nitric acid with water to a concentration ranging from about 83 to about 85% followed by treatment with an amount of an agent able to remove nitrous acid and nitrogen oxides present therein. Said agent can be, for example, urea or sulfamic acid, preferably urea, in amounts ranging from about 0.3 to about 1% w/w. The same result can be obtained by addition of an aqueous solution of said agent to fuming nitric acid. The contact time of said agent with nitric acid required to completely remove the nitrous acid and nitrogen oxides ranges from about 80 minutes to about 130 minutes. When said agent is urea, the amount ranges from about 0.6 to about 1% w/w, preferably from about 0.7 to about 1% w/w and the contact time preferably ranges from about 95 to about 120 minutes.
- The “stabilized” nitric acid according to the invention should be used within approx. three hours from stabilization, as in time nitrous acid and nitrogen oxides are released again in such concentrations as to trigger strong decomposition reactions.
- The weight ratio of “stabilized” nitric acid to 1,4-butanediol preferably ranges from about 11:1 to about 14.5:1 and the nitration is preferably carried out for a time ranging between about 10 and about 30 minutes.
- In this manner industrially advantageous yields in 1,4-butanediol mononitrate are obtained and hazards for operators are lower than those associated with nitration with concentrated nitric acid, sometimes added with sulfuric acid or urea to remove nitrous acid.
- Before being subjected to the extraction process of the invention, the nitrated solution can be treated to remove by-products and unreacted starting products, then suitably concentrated. Said solution is, in fact, a crude mixture of BDMN, by-product BDDN, unreacted BD and nitric acid in the organic solvent, also containing other by-products deriving from dehydration and/or oxidation. The solution is first partially neutralized with a sodium hydroxide concentrated solution, thus extracting most of the unreacted BD in the resulting sodium nitrate aqueous solution. The organic phase is then concentrated by evaporation and neutralized with a diluted basic solution.
- The solution subjected to the separation process of the invention preferably contains BDMN in amounts ranging from about 11% to about 15% w/w, preferably 11% w/w; BDDN in amounts ranging from about 3 to about 4.5% w/w, preferably 4%; BD in amounts ranging from about 0.2 to about 0.8% w/w (with respect to BDMN). The extraction is more efficient with more concentrated solutions, but when total nitroesters concentrations are above 15% w/w, the solutions have explosive character.
- The extraction according to steps a) and b) is preferably carried out using two or more liquid-liquid counter-current extraction columns, preferably two, three or four, more preferably two, herein referred to as column (A), for step a) and column (B), for step b). Columns (A) and (B) are preferably plate columns having 45-55 plates and optionally a decanter at the top and one at the bottom. Particularly suitable are liquid-liquid counter-current extraction columns for nominal flow rates of about 5-50 l/h, with a decanter at the top and one at the bottom. According to a particularly preferred extraction method, said extractions are carried out with columns mod. E60/50G from Kühni (Basilea-Switzerland).
- The two extractions are carried out at temperatures compatible with the thermal stability of BDMN and BDDN, namely at a temperature below the boiling point of the organic solvent, preferably at room temperature.
-
FIG. 1 shows the essential elements of a purification plant according to the invention, namely extraction column (A), extraction column (B) and a reactor (C) for the optional step c), wherein the process is carried out using dichloromethane as the solvent. When dichloromethane is replaced with an organic solvent lighter than water, fluids will be fed to the extraction columns (A) and (B) in an opposite manner. - For extraction step a), the dichloromethane solution of BDMN, BDDN and BD, i.e. the “crude” obtainable form the treatment described above, is fed to the top of a first extraction column (A), while water is fed to the bottom of said column. All the residual BD, most of the BDMN and a very small aliquot of BDDN in aqueous solution exit the top decanter of column (A). The raffinate consisting of a dichloromethane solution containing most of the BDDN and a small amount of BDMN exits the bottom of the column.
- For extraction step b), the aqueous solution of BDMN, residual BD and the very small amount of BDDN from the first extraction column (A) is fed to the base of a second extraction column (B), while fresh dichloromethane is fed to the head. Water with all the residual BD and some BDMN exit the head of the second column, while the extract, i.e. a dichoromethane solution containing purified BDMN and the negligible amount of BDDN, exit the bottom.
- Optional step c), which is carried out in an extractor (C), allows to increase the purity level of BDMN and can be effected as follows. The aqueous solution exiting the first extraction column (A) is treated with a suitable amount of dichloromethane ranging from about 7 to about 20% w/w with respect to the chloromethylene solution fed to the column (A). Treatment allows to remove BDDN which, although sparingly water-soluble (solubility <0.05%), is still present at rather high concentrations compared with BDMN (approx. 1-2%). Extractor (C) can be, for example, a conventional reactor, with a decanter downstream. After decantation, the aqueous phase now substantially containing only BDMN and the residual BD is fed to the second extraction column (B). The organic phase containing BDDN is recycled.
- For step d), the aqueous phase from the second extraction column (B), containing a very small amount of BDMN, is mixed with the dichloromethane raffinate from column (A), which in turn contains a small amount of BDMN. Extraction and subsequent decantation provide an aqueous phase enriched in BDMN, which is recycled to the first extraction column (A). In this manner, yield in BDMN can be further increased.
- From the scheme reported in
FIG. 1 it is evident that the process of the invention also provides a remarkable savings of extraction water. In fact, water that contains the residual BD exiting the top of the second extraction column (B) is recycled to the first extraction column (A) until its content in BD is compatible with the extraction process. - From the above description it will be appreciated that the process of the invention allows to separate BDMN from BD and BDDN with low hazards, good selectivity and high yields. The extraction yield (expressed as percentage ratio of purified BDMN to BDMN present in the crude solution) is above 90% w/w.
- Furthermore, the resulting organic solution contains highly pure BDMN, typically above 99.0% pure. For example, the dichloromethane solution contains BDMN with purity from about 99.5 to about 99.9%, in amounts ranging from about 5 to about 8% w/w. The solution is therefore substantially free from BDDN. The residual amount of BDDN in the organic solvent is, in fact, below 0.2% and in case of dichloromethane is below 0.15%.
- If desired, once the extraction is completed, the purified BDMN organic solution can be finally concentrated, for example under reduced pressure, to a concentration of about 15% w/w in order to make transport or storage easier. The use of solutions with higher BDMN contents can be potentially dangerous to operators.
- The present invention is further illustrated by the following examples.
- Two extraction columns Kühni mod. E60/50G are used. The crude solution (containing about 11% BDMN and about 4% BDDN) is fed (6.5 kg/h) to the top of the first column, wherein it encounters the extracted water (42.3 kg/h) (containing about 0.3% of BDMN) that exit the top of the second column and flows backwards. The raffinate (containing about 0.6% BDMN and about 6% BDDN) exits the bottom of the first column and extraction water (42.9 kg/h), rich in BDMN (about 1.6% BDMN and <0.05% BDDN) exits the top and is passed through de-emulsifier, then fed to the bottom of the second column, wherein it encounters fresh dichloromethane flowing backwards (11.1/h). Water with some BDMN exits the top of second column and is recycled to the first column, while the dichloromethane solution containing purified BDMN (about 6% w/w BDMN) exits the bottom. BDMN, which has 99.5% purity (0.5% of BDDN) in the extract, is then concentrated to 15% w/w. The extraction yield, expressed as the ratio of purified BDMN to BDMN present in the crude solution, is about 94% w/w.
- The plant is substantially the same as that of example 1, in which a 5 liters reactor equipped with a stirring system and a separator is fitted between the two distillation columns. In this step, BDDN solubilised in the water exiting the top of the first column is extracted with dichloromethane (1.0 kg/h) and recycled after separation. The final extract is thus sufficiently pure (BDDN <0.1%).
- A stainless steel reactor, equipped with condenser and stirrer, is loaded with 90 kg of diluted nitric acid (84.7%), with nitrous acid content of approx. 0.09%. The nitric acid solution is added with 675 g of urea beads, under stirring. The solution is kept under stirring for about 90 minutes, then disappearance of all the nitrous acid and nitrogen oxides is checked, both by observation of the color of the solution and determination with permanganate. If necessary, further urea is added in small portions, until complete removal of the nitrous acid and nitrogen oxides.
- A stainless steel reactor is loaded in succession with 931 g of dichloromethane and 385 g of “stabilized” nitric acid. The dispersion is cooled to about 0° C. under stirring, then 50 g of a 70/30 solution of 1,4-butanediol in dichloromethane is added in a single portion. The reaction mixture is kept under stirring at temperatures ranging from about −2° C. to 2° C. Nitration kinetics is monitored on samples of the reaction mixture. After 20 minutes the reaction is quickly quenched by pouring it into an ice/water (385 g) mixture, then neutralized with 433 g of 40% NaOH, keeping the temperature below 15° C. The organic phase containing 1,4-butanediol-mononitrate (19.2 g), 1,4-butanediol-dinitrate (6.4 g) and 1,4-butanediol (0.1 g) is then separated and subjected to the subsequent purification.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/166,739 US7947855B2 (en) | 2002-11-14 | 2008-07-02 | Process for the purification of 1,4-butanediol mononitrate |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT002409A ITMI20022409A1 (en) | 2002-11-14 | 2002-11-14 | PURIFICATION PROCEDURE FOR 1, 4-BUTANDIOL MONONITRATE. |
ITMI2002A002409 | 2002-11-14 | ||
PCT/EP2003/012375 WO2004043897A1 (en) | 2002-11-14 | 2003-11-06 | A process for the purification of 1,4-butanediol mononitrate |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/166,739 Division US7947855B2 (en) | 2002-11-14 | 2008-07-02 | Process for the purification of 1,4-butanediol mononitrate |
Publications (1)
Publication Number | Publication Date |
---|---|
US20060135806A1 true US20060135806A1 (en) | 2006-06-22 |
Family
ID=32310161
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/534,867 Abandoned US20060135806A1 (en) | 2002-11-14 | 2003-11-06 | Process for the purification of 1,4-butanediol mononitrate |
US12/166,739 Expired - Fee Related US7947855B2 (en) | 2002-11-14 | 2008-07-02 | Process for the purification of 1,4-butanediol mononitrate |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/166,739 Expired - Fee Related US7947855B2 (en) | 2002-11-14 | 2008-07-02 | Process for the purification of 1,4-butanediol mononitrate |
Country Status (15)
Country | Link |
---|---|
US (2) | US20060135806A1 (en) |
EP (1) | EP1560805B1 (en) |
JP (1) | JP4558497B2 (en) |
AT (1) | ATE366236T1 (en) |
AU (1) | AU2003285318A1 (en) |
DE (1) | DE60314769T2 (en) |
DK (1) | DK1560805T3 (en) |
ES (1) | ES2287541T3 (en) |
HR (1) | HRP20050415B1 (en) |
IL (1) | IL168540A (en) |
IT (1) | ITMI20022409A1 (en) |
NO (1) | NO20052329D0 (en) |
PL (1) | PL376973A1 (en) |
PT (1) | PT1560805E (en) |
WO (1) | WO2004043897A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110034720A1 (en) * | 2007-12-20 | 2011-02-10 | Sascha Braune | Formation of nitrate esters in microreactors and millireactors using a continuous product extraction in a turbulent flow regime |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL1814840T3 (en) | 2004-11-25 | 2010-05-31 | Nicox Sa | Process for preparing halogenoalkylnitrates |
TW201139337A (en) | 2010-03-31 | 2011-11-16 | Lonza Ag | Process for the production of esters of nitric acid |
CN102964255B (en) * | 2012-12-04 | 2013-12-25 | 山东力宝得化工股份有限公司 | Safe production method for alkyl nitrate |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2757159B1 (en) * | 1996-12-12 | 1999-12-17 | Hoechst Marion Roussel Inc | NOVEL ANALGESIC, ANTI-INFLAMMATORY AND ANTI-THROMBOTIC NITER DERIVATIVES, THEIR PREPARATION METHOD, THEIR APPLICATION AS MEDICAMENTS |
IT1313596B1 (en) * | 1999-08-04 | 2002-09-09 | Nicox Sa | PROCESS FOR THE PREPARATION OF NITROXIALKYL ESTERS OF NAPROXENE |
-
2002
- 2002-11-14 IT IT002409A patent/ITMI20022409A1/en unknown
-
2003
- 2003-11-06 AT AT03778304T patent/ATE366236T1/en active
- 2003-11-06 US US10/534,867 patent/US20060135806A1/en not_active Abandoned
- 2003-11-06 AU AU2003285318A patent/AU2003285318A1/en not_active Abandoned
- 2003-11-06 WO PCT/EP2003/012375 patent/WO2004043897A1/en active IP Right Grant
- 2003-11-06 EP EP03778304A patent/EP1560805B1/en not_active Expired - Lifetime
- 2003-11-06 PL PL376973A patent/PL376973A1/en not_active IP Right Cessation
- 2003-11-06 DK DK03778304T patent/DK1560805T3/en active
- 2003-11-06 ES ES03778304T patent/ES2287541T3/en not_active Expired - Lifetime
- 2003-11-06 JP JP2004550943A patent/JP4558497B2/en not_active Expired - Fee Related
- 2003-11-06 DE DE60314769T patent/DE60314769T2/en not_active Expired - Lifetime
- 2003-11-06 PT PT03778304T patent/PT1560805E/en unknown
-
2005
- 2005-05-10 HR HR20050415A patent/HRP20050415B1/en not_active IP Right Cessation
- 2005-05-11 IL IL168540A patent/IL168540A/en not_active IP Right Cessation
- 2005-05-12 NO NO20052329A patent/NO20052329D0/en not_active Application Discontinuation
-
2008
- 2008-07-02 US US12/166,739 patent/US7947855B2/en not_active Expired - Fee Related
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110034720A1 (en) * | 2007-12-20 | 2011-02-10 | Sascha Braune | Formation of nitrate esters in microreactors and millireactors using a continuous product extraction in a turbulent flow regime |
US8536366B2 (en) * | 2007-12-20 | 2013-09-17 | Dsm Fine Chemicals Austria Nfg Gmbh & Co Kg | Formation of nitrate esters in microreactors and millireactors using a continuous product extraction in a turbulent flow regime |
Also Published As
Publication number | Publication date |
---|---|
PL376973A1 (en) | 2006-01-23 |
EP1560805B1 (en) | 2007-07-04 |
DE60314769D1 (en) | 2007-08-16 |
WO2004043897A1 (en) | 2004-05-27 |
EP1560805A1 (en) | 2005-08-10 |
HRP20050415A2 (en) | 2005-10-31 |
NO20052329L (en) | 2005-05-12 |
ITMI20022409A1 (en) | 2004-05-15 |
PT1560805E (en) | 2007-09-04 |
AU2003285318A1 (en) | 2004-06-03 |
DE60314769T2 (en) | 2008-04-10 |
ES2287541T3 (en) | 2007-12-16 |
JP2006506417A (en) | 2006-02-23 |
DK1560805T3 (en) | 2007-11-05 |
US7947855B2 (en) | 2011-05-24 |
JP4558497B2 (en) | 2010-10-06 |
HRP20050415B1 (en) | 2008-07-31 |
IL168540A (en) | 2010-04-15 |
US20080293961A1 (en) | 2008-11-27 |
NO20052329D0 (en) | 2005-05-12 |
ATE366236T1 (en) | 2007-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7851649B2 (en) | Process for the mononitration of alkanediols | |
US6936741B2 (en) | Process for working up the waste water obtained in the preparation of dinitrotoluene | |
US10125088B2 (en) | Method for removing impurities from dinitrotoluenes | |
US7947855B2 (en) | Process for the purification of 1,4-butanediol mononitrate | |
NZ208387A (en) | Manufacture of organic nitrites | |
JP2017531641A (en) | Exhaust gas cleaning in continuous production process of dinitrotoluene | |
KR100777485B1 (en) | Continuous Isothermal Process for Preparing Mononitrotoluens | |
US4642396A (en) | Process for separating nitroaromatic compounds from spent nitric acid | |
Duehr | Nitration technology for aromatics as described in the patent literature | |
RU2293722C9 (en) | Method of continuous isothermal production of mononitrotoluenes at presence of the phosphoric acid | |
US5030769A (en) | Continuous direct preparation of nitrophenols | |
EP0169441B1 (en) | Production of dinitrotoluene | |
JPS60260543A (en) | Isolation of aromatic monoamine from amine mixture |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: DIPHARMA S.P.A., ITALY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SCUBLA, TIZIANO;FRANCESCUTTI, NEVIO;GORASSINI, FAUSTO;AND OTHERS;REEL/FRAME:016955/0735 Effective date: 20050412 Owner name: DIPHARMA S.P.A., ITALY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SCUBLA, TIZIANO;FRANCESCUTTI, NEVIO;GORASSINI, FAUSTO;AND OTHERS;REEL/FRAME:016955/0472 Effective date: 20050412 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |